chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 0.58
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling
Clinical narrative: Patient received #2 Moderna Covid vaccine in office. After patient waited the 15 min mom said that her lips looked like they were a little swollen. Brought Nurse in to look at patient, she determined that her lips were swollen and advised to give 2 ml's of benadryl, this was given and patient's mom instructed to wait an additional 15 min in office to see if swelling went down. Swelling was noted to be gone after the 15 minutes of waiting
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against then tested positive for COVID-19
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against then tested positive for COVID-19
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Asthma, Condition aggravated
Clinical narrative: I did not have an adverse reaction to the vaccine. I have had asthma for many years, and it was under control. On my ride home on 12/22/2022, my asthma starting again. As of today, I am still recovering for that episode.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalized with covid; fully vaccinated
Age: 52.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalized with covid; fully vaccinated with 2 boosters
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalized with covid; fully vaccinated
Age: 83.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: hospitalized with covid; fully vaccinated with booster
Age: 56.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Arrhythmia, Electrocardiogram abnormal
Clinical narrative: Heart arrhythmia within days after vaccination. I thought it would eventually go away but it has not so I finally went to the doctor. Dr gave me an EKG and has changed my blood pressure med to Metoprolol. I need to have a Holtor monitor placed for 48 hours and then need to see a cardiologist.
Age: 5.0
Sex: M
Vaccine: DTAPHEPBIP
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Staff nurse was given order to administer Dtap and Polio, but instead she administered Pediarix (Dtap-Hep B-IPV). Ordering provider aware. Child tolerated well, no adverse effects.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: hospitalized with covid; fully vaccinated
Age: 58.0
Sex: F
Vaccine: COVID19-2
Symptoms: Extra dose administered, Inappropriate schedule of product administration
Clinical narrative: Booster dose given after receiving a bivalent dose on 11/21/2022
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cerebrovascular accident, SARS-CoV-2 test positive
Clinical narrative: hospitalized with covid; fully vaccinated with booster
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anticoagulant therapy, Cerebrovascular accident, Computerised tomogram thorax, Hypoaesthesia, Laboratory test
Clinical narrative: Stroke(s) 40 days after 3rd booster, second stroke 60 days hospitalized after 3rd booster.. Clot in thymus
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Magnetic resonance imaging, Thrombosis
Clinical narrative: Stroke(s) 40 days after 3rd booster, second stroke 60 days hospitalized after 3rd booster.. Clot in thymus
Age: 0.83
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, Fatigue, SARS-CoV-2 test positive
Clinical narrative: 12/05/2021 a child at his daycare tested positive so we began testing daily. 12/09/2021 at about 07:00 I tested him and he tested positive. Had really no symptoms, just a little more tired than usual.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Anticoagulant therapy, Atrial fibrillation, Blood creatinine increased, Blood thyroid stimulating hormone
Clinical narrative: COVID+ 1/15/2023.  Vaccination status - moderna x3 + pfizer x1 BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: MD Admission Date: 1/15/2023 Discharge Date: Jan 19, 2023   Active Hospital Problems   Diagnosis Date Noted POA ? History of COVID-19 01/16/2023 Yes ? AKI (acute kidney injury) 01/16/2023 Yes ? Paroxysmal atrial fibrillation 01/16/2023 Yes ? History of stroke 01/16/2023 Yes ? OSA (obstructive sleep apnea) 03/22/2016 Yes ? HTN (hypertension) 04/09/2013 Yes ? Unspecified hypothyroidism 04/09/2013 Yes ? Stage 3b chronic kidney disease 04/09/2013 Yes  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Altered mental state [R41.82] Weakness [R53.1] Acute cystitis without hematuria [N30.00] Right sided weakness [R53.1]   HOSPITAL COURSE: 89-year-old admitted on 1/15 with findings of altered mental status and transient stroke-like symptoms including right-sided facial weakness and evidence of previous stroke.  Evaluation emergency room showed abnormal urine with large amount of leukocytes, and the patient reported some dysuria.  Patient was placed on ceftriaxone and cultures subsequently were positive for Proteus sensitive to all.  Patient received 3 days of ceftriaxone which was then discontinued.  Neurology was consulted and recommended brain MRI.  The patient had previously undergone MRI procedures and had difficulty with general anesthesia so the family was reluctant to repeat an MRI with general anesthesia.  After extensive discussion with Neurology it was recommended that the patient consider therapeutic anticoagulation because of past history of stroke, recent episode of COVID, and known atrial fibrillation.  Previously it was felt that the patient had to high fall risk to warrant therapeutic anticoagulation.  After additional discussion and evaluation by Physical therapy it was felt that therapeutic anticoagulation would be reasonable to pursue.  The patient's neurologic symptoms resolved.  At the time of admission the patient was also noted to have acute kidney injury on top of CKD.  This was treated with IV fluid rehydration and discontinuation of the patient's lisinopril.  Patient's initial creatinine was 2.29, his creatinine improved to 1.9 on 1/17.  Patient's baseline creatinine is between 1.3 and 1.4.  The patient was started on Eliquis 2.5 mg 2 times a day on 01/17.  If his renal function continues to improve the Eliquis dosage may need to be increased. Patient also noted to have bradycardia with afib with heart rate in 40s at times not on rate control medication without significant symptoms occasional report of dizziness with mobility and amlodipine further decreased . Family had previously decided against pace maker and decision not to send with heart monitor as they would not want intervention.  Patient was discharged in improved condition on 1/19.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Bradycardia, COVID-19, Cerebrovascular accident, Culture positive, Culture urine
Clinical narrative: COVID+ 1/15/2023.  Vaccination status - moderna x3 + pfizer x1 BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: MD Admission Date: 1/15/2023 Discharge Date: Jan 19, 2023   Active Hospital Problems   Diagnosis Date Noted POA ? History of COVID-19 01/16/2023 Yes ? AKI (acute kidney injury) 01/16/2023 Yes ? Paroxysmal atrial fibrillation 01/16/2023 Yes ? History of stroke 01/16/2023 Yes ? OSA (obstructive sleep apnea) 03/22/2016 Yes ? HTN (hypertension) 04/09/2013 Yes ? Unspecified hypothyroidism 04/09/2013 Yes ? Stage 3b chronic kidney disease 04/09/2013 Yes  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Altered mental state [R41.82] Weakness [R53.1] Acute cystitis without hematuria [N30.00] Right sided weakness [R53.1]   HOSPITAL COURSE: 89-year-old admitted on 1/15 with findings of altered mental status and transient stroke-like symptoms including right-sided facial weakness and evidence of previous stroke.  Evaluation emergency room showed abnormal urine with large amount of leukocytes, and the patient reported some dysuria.  Patient was placed on ceftriaxone and cultures subsequently were positive for Proteus sensitive to all.  Patient received 3 days of ceftriaxone which was then discontinued.  Neurology was consulted and recommended brain MRI.  The patient had previously undergone MRI procedures and had difficulty with general anesthesia so the family was reluctant to repeat an MRI with general anesthesia.  After extensive discussion with Neurology it was recommended that the patient consider therapeutic anticoagulation because of past history of stroke, recent episode of COVID, and known atrial fibrillation.  Previously it was felt that the patient had to high fall risk to warrant therapeutic anticoagulation.  After additional discussion and evaluation by Physical therapy it was felt that therapeutic anticoagulation would be reasonable to pursue.  The patient's neurologic symptoms resolved.  At the time of admission the patient was also noted to have acute kidney injury on top of CKD.  This was treated with IV fluid rehydration and discontinuation of the patient's lisinopril.  Patient's initial creatinine was 2.29, his creatinine improved to 1.9 on 1/17.  Patient's baseline creatinine is between 1.3 and 1.4.  The patient was started on Eliquis 2.5 mg 2 times a day on 01/17.  If his renal function continues to improve the Eliquis dosage may need to be increased. Patient also noted to have bradycardia with afib with heart rate in 40s at times not on rate control medication without significant symptoms occasional report of dizziness with mobility and amlodipine further decreased . Family had previously decided against pace maker and decision not to send with heart monitor as they would not want intervention.  Patient was discharged in improved condition on 1/19.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Cystitis, Differential white blood cell count, Dizziness, Dysuria, Electrocardiogram ambulatory
Clinical narrative: COVID+ 1/15/2023.  Vaccination status - moderna x3 + pfizer x1 BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: MD Admission Date: 1/15/2023 Discharge Date: Jan 19, 2023   Active Hospital Problems   Diagnosis Date Noted POA ? History of COVID-19 01/16/2023 Yes ? AKI (acute kidney injury) 01/16/2023 Yes ? Paroxysmal atrial fibrillation 01/16/2023 Yes ? History of stroke 01/16/2023 Yes ? OSA (obstructive sleep apnea) 03/22/2016 Yes ? HTN (hypertension) 04/09/2013 Yes ? Unspecified hypothyroidism 04/09/2013 Yes ? Stage 3b chronic kidney disease 04/09/2013 Yes  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Altered mental state [R41.82] Weakness [R53.1] Acute cystitis without hematuria [N30.00] Right sided weakness [R53.1]   HOSPITAL COURSE: 89-year-old admitted on 1/15 with findings of altered mental status and transient stroke-like symptoms including right-sided facial weakness and evidence of previous stroke.  Evaluation emergency room showed abnormal urine with large amount of leukocytes, and the patient reported some dysuria.  Patient was placed on ceftriaxone and cultures subsequently were positive for Proteus sensitive to all.  Patient received 3 days of ceftriaxone which was then discontinued.  Neurology was consulted and recommended brain MRI.  The patient had previously undergone MRI procedures and had difficulty with general anesthesia so the family was reluctant to repeat an MRI with general anesthesia.  After extensive discussion with Neurology it was recommended that the patient consider therapeutic anticoagulation because of past history of stroke, recent episode of COVID, and known atrial fibrillation.  Previously it was felt that the patient had to high fall risk to warrant therapeutic anticoagulation.  After additional discussion and evaluation by Physical therapy it was felt that therapeutic anticoagulation would be reasonable to pursue.  The patient's neurologic symptoms resolved.  At the time of admission the patient was also noted to have acute kidney injury on top of CKD.  This was treated with IV fluid rehydration and discontinuation of the patient's lisinopril.  Patient's initial creatinine was 2.29, his creatinine improved to 1.9 on 1/17.  Patient's baseline creatinine is between 1.3 and 1.4.  The patient was started on Eliquis 2.5 mg 2 times a day on 01/17.  If his renal function continues to improve the Eliquis dosage may need to be increased. Patient also noted to have bradycardia with afib with heart rate in 40s at times not on rate control medication without significant symptoms occasional report of dizziness with mobility and amlodipine further decreased . Family had previously decided against pace maker and decision not to send with heart monitor as they would not want intervention.  Patient was discharged in improved condition on 1/19.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Facial paresis, Fatigue, Full blood count, Hemiparesis, Mental status changes
Clinical narrative: COVID+ 1/15/2023.  Vaccination status - moderna x3 + pfizer x1 BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: MD Admission Date: 1/15/2023 Discharge Date: Jan 19, 2023   Active Hospital Problems   Diagnosis Date Noted POA ? History of COVID-19 01/16/2023 Yes ? AKI (acute kidney injury) 01/16/2023 Yes ? Paroxysmal atrial fibrillation 01/16/2023 Yes ? History of stroke 01/16/2023 Yes ? OSA (obstructive sleep apnea) 03/22/2016 Yes ? HTN (hypertension) 04/09/2013 Yes ? Unspecified hypothyroidism 04/09/2013 Yes ? Stage 3b chronic kidney disease 04/09/2013 Yes  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Altered mental state [R41.82] Weakness [R53.1] Acute cystitis without hematuria [N30.00] Right sided weakness [R53.1]   HOSPITAL COURSE: 89-year-old admitted on 1/15 with findings of altered mental status and transient stroke-like symptoms including right-sided facial weakness and evidence of previous stroke.  Evaluation emergency room showed abnormal urine with large amount of leukocytes, and the patient reported some dysuria.  Patient was placed on ceftriaxone and cultures subsequently were positive for Proteus sensitive to all.  Patient received 3 days of ceftriaxone which was then discontinued.  Neurology was consulted and recommended brain MRI.  The patient had previously undergone MRI procedures and had difficulty with general anesthesia so the family was reluctant to repeat an MRI with general anesthesia.  After extensive discussion with Neurology it was recommended that the patient consider therapeutic anticoagulation because of past history of stroke, recent episode of COVID, and known atrial fibrillation.  Previously it was felt that the patient had to high fall risk to warrant therapeutic anticoagulation.  After additional discussion and evaluation by Physical therapy it was felt that therapeutic anticoagulation would be reasonable to pursue.  The patient's neurologic symptoms resolved.  At the time of admission the patient was also noted to have acute kidney injury on top of CKD.  This was treated with IV fluid rehydration and discontinuation of the patient's lisinopril.  Patient's initial creatinine was 2.29, his creatinine improved to 1.9 on 1/17.  Patient's baseline creatinine is between 1.3 and 1.4.  The patient was started on Eliquis 2.5 mg 2 times a day on 01/17.  If his renal function continues to improve the Eliquis dosage may need to be increased. Patient also noted to have bradycardia with afib with heart rate in 40s at times not on rate control medication without significant symptoms occasional report of dizziness with mobility and amlodipine further decreased . Family had previously decided against pace maker and decision not to send with heart monitor as they would not want intervention.  Patient was discharged in improved condition on 1/19.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Metabolic function test, Mobility decreased, Neurological symptom, Proteus test positive, Renal impairment
Clinical narrative: COVID+ 1/15/2023.  Vaccination status - moderna x3 + pfizer x1 BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: MD Admission Date: 1/15/2023 Discharge Date: Jan 19, 2023   Active Hospital Problems   Diagnosis Date Noted POA ? History of COVID-19 01/16/2023 Yes ? AKI (acute kidney injury) 01/16/2023 Yes ? Paroxysmal atrial fibrillation 01/16/2023 Yes ? History of stroke 01/16/2023 Yes ? OSA (obstructive sleep apnea) 03/22/2016 Yes ? HTN (hypertension) 04/09/2013 Yes ? Unspecified hypothyroidism 04/09/2013 Yes ? Stage 3b chronic kidney disease 04/09/2013 Yes  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Altered mental state [R41.82] Weakness [R53.1] Acute cystitis without hematuria [N30.00] Right sided weakness [R53.1]   HOSPITAL COURSE: 89-year-old admitted on 1/15 with findings of altered mental status and transient stroke-like symptoms including right-sided facial weakness and evidence of previous stroke.  Evaluation emergency room showed abnormal urine with large amount of leukocytes, and the patient reported some dysuria.  Patient was placed on ceftriaxone and cultures subsequently were positive for Proteus sensitive to all.  Patient received 3 days of ceftriaxone which was then discontinued.  Neurology was consulted and recommended brain MRI.  The patient had previously undergone MRI procedures and had difficulty with general anesthesia so the family was reluctant to repeat an MRI with general anesthesia.  After extensive discussion with Neurology it was recommended that the patient consider therapeutic anticoagulation because of past history of stroke, recent episode of COVID, and known atrial fibrillation.  Previously it was felt that the patient had to high fall risk to warrant therapeutic anticoagulation.  After additional discussion and evaluation by Physical therapy it was felt that therapeutic anticoagulation would be reasonable to pursue.  The patient's neurologic symptoms resolved.  At the time of admission the patient was also noted to have acute kidney injury on top of CKD.  This was treated with IV fluid rehydration and discontinuation of the patient's lisinopril.  Patient's initial creatinine was 2.29, his creatinine improved to 1.9 on 1/17.  Patient's baseline creatinine is between 1.3 and 1.4.  The patient was started on Eliquis 2.5 mg 2 times a day on 01/17.  If his renal function continues to improve the Eliquis dosage may need to be increased. Patient also noted to have bradycardia with afib with heart rate in 40s at times not on rate control medication without significant symptoms occasional report of dizziness with mobility and amlodipine further decreased . Family had previously decided against pace maker and decision not to send with heart monitor as they would not want intervention.  Patient was discharged in improved condition on 1/19.
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Thyroxine free, Urine analysis, Urine analysis abnormal, White blood cells urine positive
Clinical narrative: COVID+ 1/15/2023.  Vaccination status - moderna x3 + pfizer x1 BRIEF OVERVIEW: Discharge Provider: MD Primary Care Provider: MD Admission Date: 1/15/2023 Discharge Date: Jan 19, 2023   Active Hospital Problems   Diagnosis Date Noted POA ? History of COVID-19 01/16/2023 Yes ? AKI (acute kidney injury) 01/16/2023 Yes ? Paroxysmal atrial fibrillation 01/16/2023 Yes ? History of stroke 01/16/2023 Yes ? OSA (obstructive sleep apnea) 03/22/2016 Yes ? HTN (hypertension) 04/09/2013 Yes ? Unspecified hypothyroidism 04/09/2013 Yes ? Stage 3b chronic kidney disease 04/09/2013 Yes  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Altered mental state [R41.82] Weakness [R53.1] Acute cystitis without hematuria [N30.00] Right sided weakness [R53.1]   HOSPITAL COURSE: 89-year-old admitted on 1/15 with findings of altered mental status and transient stroke-like symptoms including right-sided facial weakness and evidence of previous stroke.  Evaluation emergency room showed abnormal urine with large amount of leukocytes, and the patient reported some dysuria.  Patient was placed on ceftriaxone and cultures subsequently were positive for Proteus sensitive to all.  Patient received 3 days of ceftriaxone which was then discontinued.  Neurology was consulted and recommended brain MRI.  The patient had previously undergone MRI procedures and had difficulty with general anesthesia so the family was reluctant to repeat an MRI with general anesthesia.  After extensive discussion with Neurology it was recommended that the patient consider therapeutic anticoagulation because of past history of stroke, recent episode of COVID, and known atrial fibrillation.  Previously it was felt that the patient had to high fall risk to warrant therapeutic anticoagulation.  After additional discussion and evaluation by Physical therapy it was felt that therapeutic anticoagulation would be reasonable to pursue.  The patient's neurologic symptoms resolved.  At the time of admission the patient was also noted to have acute kidney injury on top of CKD.  This was treated with IV fluid rehydration and discontinuation of the patient's lisinopril.  Patient's initial creatinine was 2.29, his creatinine improved to 1.9 on 1/17.  Patient's baseline creatinine is between 1.3 and 1.4.  The patient was started on Eliquis 2.5 mg 2 times a day on 01/17.  If his renal function continues to improve the Eliquis dosage may need to be increased. Patient also noted to have bradycardia with afib with heart rate in 40s at times not on rate control medication without significant symptoms occasional report of dizziness with mobility and amlodipine further decreased . Family had previously decided against pace maker and decision not to send with heart monitor as they would not want intervention.  Patient was discharged in improved condition on 1/19.
Age: 94.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Booster dose administered after receiving a bivalent dose on 11/17/2022
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Injected Pediatric dose instead of Bivalent Adult dose and the patient did not get any adverse effect.  The Moderna vial  and box did not indicate any writing stating that it was a pediatric vial.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest discomfort, SARS-CoV-2 test positive, Ventricular extrasystoles
Clinical narrative: On 01/22/2022, I developed an anxious feeling in my chest. I ignored it for a while, but I did see my doctor.  I was diagnosed in September 2022 with PVC. I take an aspirin on a daily basis now. I previous tested positive for COVID-19 in 09/2022 and 08/2021
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Cerebral atrophy, Cerebral infarction, Cerebral small vessel ischaemic disease, Cerebrovascular accident, Computerised tomogram head
Clinical narrative: Around 0400 pt was up to the BR and her heart was racing.  At 0800 when she went to get up her legs gave way. She called her family and family indicated her speech was garbled and difficult to understand. Patient was transported to ER on 12/04/2023 by ambulance at 0846. CTA Head/Neck completed on 12-04-2022 IMPRESSION: 1. No significant stenosis or occlusion of vertebrobasilar or internal carotid arteries. 2. Compression of the medulla by hypertrophied atlantoaxial extraaxial joint capsule where there are degenerative changes.  Suggest correlation with MRI.  CT Head on 12/04/2022: 1. Age related changes                                               2. Chronic ischemic disease                                               3. No bleeding   MRI 12/05/2022 : 1.Recent small ischemic infarct n the left sylvian lobe and adjacent parietal lobe.                                   2. Atrophy and moderated chronic small vessel ischemic white matter change.                                  Course by ER MD on 12/05/22 at 1700 -The patient was seen and examined. Speech and neuro exam non focal at discharge.  Pt completed f/u with PCP in a week for a Holter monitor,  BP monitor, and adjustment of hypertensive medications.   Pt had a two week f/u with cardiology on 12/21/2022.  Transthoracic ECHO was ordered by Cardiologist.  01-20-2023- I received a call from the patient on 01/20/2023.  She call the health department to let us know that she had a stroke on 12-04-2022 subsequent to receiving a Moderna Bivalent Booster on 11/29/2022. After questioning the patient as to whether any of the HCP's completed a VAERS form, she indicated they had not.  Her daughter is a PA and thought the patient should call us and let us know.  I instructed the patient the health department would complete the VAERS form and submit it for reporting the incident.  I also instructed the patient that someone from the VAERS system may call her for additional information.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Echocardiogram, Electrocardiogram ambulatory, Loss of control of legs, Magnetic resonance imaging head, Palpitations
Clinical narrative: Around 0400 pt was up to the BR and her heart was racing.  At 0800 when she went to get up her legs gave way. She called her family and family indicated her speech was garbled and difficult to understand. Patient was transported to ER on 12/04/2023 by ambulance at 0846. CTA Head/Neck completed on 12-04-2022 IMPRESSION: 1. No significant stenosis or occlusion of vertebrobasilar or internal carotid arteries. 2. Compression of the medulla by hypertrophied atlantoaxial extraaxial joint capsule where there are degenerative changes.  Suggest correlation with MRI.  CT Head on 12/04/2022: 1. Age related changes                                               2. Chronic ischemic disease                                               3. No bleeding   MRI 12/05/2022 : 1.Recent small ischemic infarct n the left sylvian lobe and adjacent parietal lobe.                                   2. Atrophy and moderated chronic small vessel ischemic white matter change.                                  Course by ER MD on 12/05/22 at 1700 -The patient was seen and examined. Speech and neuro exam non focal at discharge.  Pt completed f/u with PCP in a week for a Holter monitor,  BP monitor, and adjustment of hypertensive medications.   Pt had a two week f/u with cardiology on 12/21/2022.  Transthoracic ECHO was ordered by Cardiologist.  01-20-2023- I received a call from the patient on 01/20/2023.  She call the health department to let us know that she had a stroke on 12-04-2022 subsequent to receiving a Moderna Bivalent Booster on 11/29/2022. After questioning the patient as to whether any of the HCP's completed a VAERS form, she indicated they had not.  Her daughter is a PA and thought the patient should call us and let us know.  I instructed the patient the health department would complete the VAERS form and submit it for reporting the incident.  I also instructed the patient that someone from the VAERS system may call her for additional information.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Speech disorder
Clinical narrative: Around 0400 pt was up to the BR and her heart was racing.  At 0800 when she went to get up her legs gave way. She called her family and family indicated her speech was garbled and difficult to understand. Patient was transported to ER on 12/04/2023 by ambulance at 0846. CTA Head/Neck completed on 12-04-2022 IMPRESSION: 1. No significant stenosis or occlusion of vertebrobasilar or internal carotid arteries. 2. Compression of the medulla by hypertrophied atlantoaxial extraaxial joint capsule where there are degenerative changes.  Suggest correlation with MRI.  CT Head on 12/04/2022: 1. Age related changes                                               2. Chronic ischemic disease                                               3. No bleeding   MRI 12/05/2022 : 1.Recent small ischemic infarct n the left sylvian lobe and adjacent parietal lobe.                                   2. Atrophy and moderated chronic small vessel ischemic white matter change.                                  Course by ER MD on 12/05/22 at 1700 -The patient was seen and examined. Speech and neuro exam non focal at discharge.  Pt completed f/u with PCP in a week for a Holter monitor,  BP monitor, and adjustment of hypertensive medications.   Pt had a two week f/u with cardiology on 12/21/2022.  Transthoracic ECHO was ordered by Cardiologist.  01-20-2023- I received a call from the patient on 01/20/2023.  She call the health department to let us know that she had a stroke on 12-04-2022 subsequent to receiving a Moderna Bivalent Booster on 11/29/2022. After questioning the patient as to whether any of the HCP's completed a VAERS form, she indicated they had not.  Her daughter is a PA and thought the patient should call us and let us know.  I instructed the patient the health department would complete the VAERS form and submit it for reporting the incident.  I also instructed the patient that someone from the VAERS system may call her for additional information.
Age: 52.0
Sex: M
Vaccine: UNK
Symptoms: Gait inability, Mass
Clinical narrative: None stated.
Age: 56.0
Sex: M
Vaccine: COVID19-2
Symptoms: Blood pressure increased, Headache, Influenza, Pain
Clinical narrative: Flu systems: body aches low grade fever(<99).  Blood pressure elevated and has not come back to normal range sense 1/15/23. Constant headache along with elevated blood pressure. Range / average measured (160/100). Dr. brought me in to office 1/19/23 gave me a blood pressure med and it lowered to normal level. Issued prescription for Verapamil er 120 Mg, it has little to no effect. I will be calling Dr's office as soon as I'm finished typing this report.
Age: 61.0
Sex: M
Vaccine: VARZOS
Symptoms: Aortic dilatation, Bundle branch block, Cardiac disorder, Cardiac flutter, Cardiac perfusion defect
Clinical narrative: I came down with flu-like symptoms within four hours on the vaccine: severe fatigue, aches in most muscles, tiredness, chills and sweats. These symptoms faded on the evening of the second day after my vaccine, but then in the evening of 9/22/22, I began feeling strong heart flutters, with pressure in my chest during the skipped beats. This continued for the next few days and I scheduled an appointment with my primary. On 9/26/22, my primary put a Holter monitor on me for 48 hours. It showed PVCs with a burden of 8%. My primary then put me on Metropolol, which I took for several days, but it did not help and the side effects were too unpleasant.  Over the next few days/weeks, the PVCs became more frequent, making it difficult to sleep. I then scheduled an appointment with an electrophysiologist. On 10/26/22, Dr. ordered an MRI and stress tests. The tests showed I had a borderline enlarged aortic root, PVC's, and several other issues such as a partial  bundle branch blockage, reduced perfusion during exercise. These results were reviewed by Dr. who then referred me to a cardiologist, at the same facility. I saw Dr. on 1/6/23, and he still heard the PVCs. He referred me for further study (heart CT), which is pending. Although the PVCs has lessened in frequency, the still occur at various times throughout the day, especially when laying down. I had never had PVCs before the vaccine and have had numerous EKGs before surgical procedures.
Age: 61.0
Sex: M
Vaccine: VARZOS
Symptoms: Cardiac stress test abnormal, Chest discomfort, Chills, Electrocardiogram, Electrocardiogram ambulatory abnormal
Clinical narrative: I came down with flu-like symptoms within four hours on the vaccine: severe fatigue, aches in most muscles, tiredness, chills and sweats. These symptoms faded on the evening of the second day after my vaccine, but then in the evening of 9/22/22, I began feeling strong heart flutters, with pressure in my chest during the skipped beats. This continued for the next few days and I scheduled an appointment with my primary. On 9/26/22, my primary put a Holter monitor on me for 48 hours. It showed PVCs with a burden of 8%. My primary then put me on Metropolol, which I took for several days, but it did not help and the side effects were too unpleasant.  Over the next few days/weeks, the PVCs became more frequent, making it difficult to sleep. I then scheduled an appointment with an electrophysiologist. On 10/26/22, Dr. ordered an MRI and stress tests. The tests showed I had a borderline enlarged aortic root, PVC's, and several other issues such as a partial  bundle branch blockage, reduced perfusion during exercise. These results were reviewed by Dr. who then referred me to a cardiologist, at the same facility. I saw Dr. on 1/6/23, and he still heard the PVCs. He referred me for further study (heart CT), which is pending. Although the PVCs has lessened in frequency, the still occur at various times throughout the day, especially when laying down. I had never had PVCs before the vaccine and have had numerous EKGs before surgical procedures.
Age: 61.0
Sex: M
Vaccine: VARZOS
Symptoms: Exercise test abnormal, Extrasystoles, Fatigue, Hyperhidrosis, Influenza like illness
Clinical narrative: I came down with flu-like symptoms within four hours on the vaccine: severe fatigue, aches in most muscles, tiredness, chills and sweats. These symptoms faded on the evening of the second day after my vaccine, but then in the evening of 9/22/22, I began feeling strong heart flutters, with pressure in my chest during the skipped beats. This continued for the next few days and I scheduled an appointment with my primary. On 9/26/22, my primary put a Holter monitor on me for 48 hours. It showed PVCs with a burden of 8%. My primary then put me on Metropolol, which I took for several days, but it did not help and the side effects were too unpleasant.  Over the next few days/weeks, the PVCs became more frequent, making it difficult to sleep. I then scheduled an appointment with an electrophysiologist. On 10/26/22, Dr. ordered an MRI and stress tests. The tests showed I had a borderline enlarged aortic root, PVC's, and several other issues such as a partial  bundle branch blockage, reduced perfusion during exercise. These results were reviewed by Dr. who then referred me to a cardiologist, at the same facility. I saw Dr. on 1/6/23, and he still heard the PVCs. He referred me for further study (heart CT), which is pending. Although the PVCs has lessened in frequency, the still occur at various times throughout the day, especially when laying down. I had never had PVCs before the vaccine and have had numerous EKGs before surgical procedures.
Age: 61.0
Sex: M
Vaccine: VARZOS
Symptoms: Insomnia, Magnetic resonance imaging abnormal, Myalgia, Ventricular extrasystoles
Clinical narrative: I came down with flu-like symptoms within four hours on the vaccine: severe fatigue, aches in most muscles, tiredness, chills and sweats. These symptoms faded on the evening of the second day after my vaccine, but then in the evening of 9/22/22, I began feeling strong heart flutters, with pressure in my chest during the skipped beats. This continued for the next few days and I scheduled an appointment with my primary. On 9/26/22, my primary put a Holter monitor on me for 48 hours. It showed PVCs with a burden of 8%. My primary then put me on Metropolol, which I took for several days, but it did not help and the side effects were too unpleasant.  Over the next few days/weeks, the PVCs became more frequent, making it difficult to sleep. I then scheduled an appointment with an electrophysiologist. On 10/26/22, Dr. ordered an MRI and stress tests. The tests showed I had a borderline enlarged aortic root, PVC's, and several other issues such as a partial  bundle branch blockage, reduced perfusion during exercise. These results were reviewed by Dr. who then referred me to a cardiologist, at the same facility. I saw Dr. on 1/6/23, and he still heard the PVCs. He referred me for further study (heart CT), which is pending. Although the PVCs has lessened in frequency, the still occur at various times throughout the day, especially when laying down. I had never had PVCs before the vaccine and have had numerous EKGs before surgical procedures.
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Underdose
Clinical narrative: Injected Pediatric dose instead of a Bivalent Adult dose and the patient did not get any adverse effects.  The Moderna vial and box did not indicate any writing stating that it was a pediatric vial.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Underdose
Clinical narrative: Injected Pediatric dose instead of Bivalent Adult dose and the patient did not get any adverse effect.  The Moderna vial  and box did not indicate any writing stating that it was a pediatric vial.
Age: 70.0
Sex: M
Vaccine: COVID19-2
Symptoms: Extra dose administered
Clinical narrative: Booster administered after receiving a bivalent dose on 11/21/2022
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: 12/22/22 presents to ED for "shortness of breath". PMHx of "COPD, SLE, chronic anemia, CKD"
Age: 58.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: 12/22/22 presents to ED for "fever". PMHx of "HTN, HLD, DM type 2, lymphoma"
Age: 1.25
Sex: M
Vaccine: HEPA
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient given second Hepatitis A vaccine prior to recommended due date. Second dose not due until June 2023. Patient parent informed of invalid dose and need for repeated dose.
Age: 87.0
Sex: F
Vaccine: COVID19-2
Symptoms: Extra dose administered
Clinical narrative: Booster administered after receiving a bivalent dose on 11/17/2022
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: HOSPITALIZATION
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Dysarthria, Gait inability, Headache, Magnetic resonance imaging abnormal
Clinical narrative: On 11/03/2022 I woke up at 4AM to begin my daily routine when I noticed my right leg was not working as it should and my right arm was not working as it should either I then experienced a severe headache and took an Ibuprofen.  I crawled up the stairs as I could not walk up to get help from my girlfriend.  When I was able to talk to my girlfriend my speech was slurred and she could not understand me, An ambulance was called I was taken to the hospital under stroke alert.  No immediate clotting was noticed an MRI was done and several blood clots were noted and I am currently on a blood thinner Eliquis 5mg twice daily and Lipitor.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Musculoskeletal disorder, Thrombosis
Clinical narrative: On 11/03/2022 I woke up at 4AM to begin my daily routine when I noticed my right leg was not working as it should and my right arm was not working as it should either I then experienced a severe headache and took an Ibuprofen.  I crawled up the stairs as I could not walk up to get help from my girlfriend.  When I was able to talk to my girlfriend my speech was slurred and she could not understand me, An ambulance was called I was taken to the hospital under stroke alert.  No immediate clotting was noticed an MRI was done and several blood clots were noted and I am currently on a blood thinner Eliquis 5mg twice daily and Lipitor.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Diarrhoea, Dyspnoea, Pyrexia
Clinical narrative: Cough, SOB, Fever, Diarrhea, Vomiting started on 1/16/23.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Vomiting
Clinical narrative: Cough, SOB, Fever, Diarrhea, Vomiting started on 1/16/23.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Antineutrophil cytoplasmic antibody, Inflammatory marker increased, Magnetic resonance imaging head
Clinical narrative: Onset of nose pain that resulted in uncontrollable nasal fluid at unexpected times. THe extreme nose pain continues to date.  No Doctor can figure why.   Lack of smell and taste also occurred..  Myeloperoxidase blood test revealed elevated blood inflamation count.  Norm is Approx. 135,  on Dec. 2021 I was at 1700. Next test in Feb. 2022 showed it was at 2200.  Next test in May 2022 showed 3,100!  I had (I think) every test that could be given to try and find the cause of this blood inflamation.  MRI of head, scans of sinus', teeth and gums.  Diet was explored.  Last test in Dec. 2022 showed 2,100.  I am currently taking a Statin drug to  try to  reduce the inflamation in my blood.  Cont. below My Ear, Nose, Throat Specialist cannot figure what's wrong with my nose and sinus'
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinalgia, Rhinorrhoea
Clinical narrative: Onset of nose pain that resulted in uncontrollable nasal fluid at unexpected times. THe extreme nose pain continues to date.  No Doctor can figure why.   Lack of smell and taste also occurred..  Myeloperoxidase blood test revealed elevated blood inflamation count.  Norm is Approx. 135,  on Dec. 2021 I was at 1700. Next test in Feb. 2022 showed it was at 2200.  Next test in May 2022 showed 3,100!  I had (I think) every test that could be given to try and find the cause of this blood inflamation.  MRI of head, scans of sinus', teeth and gums.  Diet was explored.  Last test in Dec. 2022 showed 2,100.  I am currently taking a Statin drug to  try to  reduce the inflamation in my blood.  Cont. below My Ear, Nose, Throat Specialist cannot figure what's wrong with my nose and sinus'
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: 12/23/22 presents to ED for "shortness of breath". PMHx of "COPD, GERD, A. fib, hypertension, CAD status post CABG x4"
Age: 61.0
Sex: M
Vaccine: PNC20
Symptoms: Chills, Computerised tomogram, Cough, Headache, Insomnia
Clinical narrative: swollen & black & blue arm, could not move arm for 2 days, fever, headache, constant cough,chills, throwing up, could not sleep, felt better around January 3rd, but still don't feel fully recovered , took melatonin, methylprednisolone 4mg dospac 21 pills, benzonatate 100mg capsules
Age: 61.0
Sex: M
Vaccine: PNC20
Symptoms: Musculoskeletal disorder, Peripheral swelling, Pyrexia, Skin discolouration, Ultrasound scan
Clinical narrative: swollen & black & blue arm, could not move arm for 2 days, fever, headache, constant cough,chills, throwing up, could not sleep, felt better around January 3rd, but still don't feel fully recovered , took melatonin, methylprednisolone 4mg dospac 21 pills, benzonatate 100mg capsules
Age: 61.0
Sex: M
Vaccine: PNC20
Symptoms: Vomiting
Clinical narrative: swollen & black & blue arm, could not move arm for 2 days, fever, headache, constant cough,chills, throwing up, could not sleep, felt better around January 3rd, but still don't feel fully recovered , took melatonin, methylprednisolone 4mg dospac 21 pills, benzonatate 100mg capsules
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: HOSPITALIZATION
Age: 85.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Cough, Dyspnoea exertional
Clinical narrative: Pt discharged home from SNF last week after admission in December post fall with UTI and T11 compression fracture. Pt having mild nonproductive cough and exertional dyspnea. Found to be COVID positive. Admitted to the hospital with acute hypoxic respiratory failure secondary to COVID pneumonia.
Age: 85.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fall, SARS-CoV-2 test positive, Spinal compression fracture, Urinary tract infection
Clinical narrative: Pt discharged home from SNF last week after admission in December post fall with UTI and T11 compression fracture. Pt having mild nonproductive cough and exertional dyspnea. Found to be COVID positive. Admitted to the hospital with acute hypoxic respiratory failure secondary to COVID pneumonia.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: admitted to local Medical Center on  1.20.2023 from alternate Memorial Hospital expired 1.23.2023
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: admitted to local Medical Center on  1.20.2023 from alternate Memorial Hospital expired 1.23.2023
Age: 51.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Ear infection, Nasal congestion, Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: I had no trouble after receiving the vaccine. I had a stuffy nose and a sore throat for a couple days before testing for COVID-19. I tested positive for COVID-19 on 12/21/2022. I contacted my doctor, and they didn't provide a prescription but recommended taking over the counter medication. I later developed an ear infection.
Age: 19.0
Sex: F
Vaccine: HEP, HEPA, IPV, MENB
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse events- expired vaccine was administered
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Death, Vaccine breakthrough infection
Clinical narrative: COVID related death, breakthrough case
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: COVID related death, breakthrough case
Age: 22.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incomplete course of vaccination, Incorrect product formulation administered
Clinical narrative: Client received one dose of Pfizer vaccine on 1/14/2023.  RN discussed restarted the vaccine series since the client never received her 2nd dose of the series.  The client agreed to restart the series however the RN administered the bivalent vaccine instead of the monovalent vaccine.  She immediately called me to report this error.  The client was informed of the vaccine she received by the nurse soon after vaccine administration. I consulted with Dr., the Mobile team Medical Director.  Dr. advised that no additional vaccine were needed for this client, since she received the bivalent vaccine. A call was made on 1/19/23 with the site contact, (client), Mobile Team Program Director, and myself (NP).  All questions and concerns were addressed with the client.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Arthritis, Computerised tomogram abnormal, Condition aggravated, High frequency ablation, Sleep disorder
Clinical narrative: I had been having some trouble with my arthritis, but within a week or two of receiving my third dose of Moderna, everything got much worse. I started treating with some physical therapy actually before my third dose and that wasn't doing anything. I received a cortisone shot which helped a bit. I received a second one and that didn't help at all. I had a procedure done called an ablation, which also didn't seem to help. It's gotten to the point now, where I'm having trouble even sleeping through the night.
Age: 9.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Product administered to patient of inappropriate age, Vaccination error
Clinical narrative: VACCINATION ERROR ONLY - NO ADVERSE EVENT REPORTED BY PATIENT. PATIENT GIVEN PFIZER BIVALENT BOOSTER FOR PATIENTS 12 YEARS AND UP WHEN PATIENT WAS 9 YEARS OLD. LOCAL REGULATOR HAS REQUESTED THAT WE REPORT THIS INCIDENCE ONCE THEY REALIZED THE ERROR.
Age: 1.25
Sex: F
Vaccine: DTPPVHBHPB, FLU4, HIBV, DTPPVHBHPB, FLU4, HIBV
Symptoms: Medication error
Clinical narrative: Medication error. Combination Vaxelis was administered instead of the ordered DTaP, resulting in extraneous dose of Hep B, out of schedule IPV and duplicate HIB vaccine. No reactions noted a tthe time of service. No report from parent/guardian of adverse reaction. Parent was notified by provider.
Age: 1.25
Sex: F
Vaccine: DTPPVHBHPB, FLU4, HIBV, DTPPVHBHPB, FLU4, HIBV
Symptoms: Medication error, No adverse event, Wrong product administered
Clinical narrative: Medication error. Combination Vaxelis was administered instead of the ordered DTaP, resulting in extraneous dose of Hep B, out of schedule IPV and duplicate HIB vaccine. No reactions noted a tthe time of service. No report from parent/guardian of adverse reaction. Parent was notified by provider.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Respiratory tract congestion
Clinical narrative: ACHES, CONGESTION
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Cough, Pneumonia, Pyrexia, Rhinorrhoea
Clinical narrative: Hospitalized 2/6/22-2/8/22 Cough, chest pain, runny nose, sepsis, PNA, fever,
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Sepsis
Clinical narrative: Hospitalized 2/6/22-2/8/22 Cough, chest pain, runny nose, sepsis, PNA, fever,